The Magazine for Sleep Professionals
Sunday, April 5, 2026
Millions of people who suffer from some form of insomnia. Whether it be brief symptoms or chronic, not getting the recommended amount of sleep is something that can affect everyday life. Lack of sleep can cause lower productivity and could be dangerous. CURE Pharmaceutical is working on a way to […]
Sunovion Pharmaceuticals Inc. today announced that the FDA approved the New Drug Application (NDA) for Lonhala™ Magnair™ (glycopyrrolate) Inhalation Solution (25 mcg twice daily), also known as SUN-101/eFlow®, for the long-term, maintenance treatment of airflow obstruction in people with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and/or emphysema. Sunovion […]
